Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Finasteride reduces hair growth and is safe for women with excessive hair.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Ganoderma lucidum may help treat enlarged prostate in rats.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.